Physician

Oksana Yevdokimova, MD

According to 2025 Medicare claims, Oksana Yevdokimova, MD (NPI: 1437290772) practices family practice in the Allentown-Bethlehem-Easton, PA-NJ market, with the plurality of this provider's patient population coming from Warren, NJ. This provider's primary affiliated billing organization is ST. LUKE'S WARREN PHYSICIAN GROUP, PC (NPI: 1295009918; TIN: 223837316) and primary practice location at 07882-4069. Yevdokimova is affiliated with the St. Luke's Medicare ACO (ACO ID: A3560), participating under the MSSP model.

Yevdokimova's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 377 traditional Medicare patients, billed 1,983 HCPCS/CPT codes, and received $144,027 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 8,230 prescription claims across 633 beneficiaries totaling $767,173 in drug costs, led by Ozempic (Semaglutide). DME data shows 81 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved from a higher plateau to a lower plateau, from $7,884 to $8,599.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	465	1,823	$116,279
2016	640	2,244	$139,515
2017	547	2,503	$172,955
2018	555	2,094	$139,762
2019	468	1,824	$129,442
2020	377	1,622	$119,419
2021	357	1,762	$135,612
2022	393	1,666	$141,357
2023	354	1,434	$124,472
2024	377	1,983	$144,027

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	524	7,876	$600,763
2016	772	8,962	$722,983
2017	712	12,138	$1,016,174
2018	612	11,149	$984,829
2019	736	10,623	$958,050
2020	549	8,178	$795,427
2021	544	8,040	$811,704
2022	674	8,107	$724,534
2023	575	7,922	$842,190
2024	633	8,230	$767,173

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	45	319	$8,868
2016	53	305	$8,854
2017	82	292	$5,774
2018	52	212	$3,282
2019	54	158	$1,533
2020	40	108	$902
2021	36	94	$1,041
2022	20	110	$4,973
2023	17	87	$2,315
2024	17	81	$1,944

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	207	207	$150
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	280	586	$97
90662	Influenza vaccine split virus, preservative free	59	60	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	146	211	$67
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	221	423	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	42	2,800	$88,637
Eliquis	Apixaban	74	3,688	$70,562
Januvia	Sitagliptin Phosphate	48	3,600	$62,754
Xarelto	Rivaroxaban	49	2,610	$47,013
Janumet Xr	Sitagliptin Phos/Metformin Hcl	47	3,450	$46,132

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	17	34	$801
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	12	$653
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	19	$466
A4259	Lancets, per box of 100	N	N/R	16	$24

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Oksana Yevdokimova, MD?

Tedicare shows public-source Medicare data for Oksana Yevdokimova, MD (NPI 1437290772), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Oksana Yevdokimova, MD have ACO affiliation data?

Oksana Yevdokimova, MD is shown with ACO affiliation data for St. Luke's Medicare ACO (MSSP, ACO ID A3560).

What billing organization is linked to Oksana Yevdokimova, MD?

Oksana Yevdokimova, MD is linked to ST. LUKE'S WARREN PHYSICIAN GROUP, PC (billing NPI 1295009918) in the available physician profile data.

Does Oksana Yevdokimova, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.